Navigation Links
Blood transfusion linked to lung ailment

The government and researchers are warning that blood transfusions can cause a serious and often-unrecognized lung problem that has been linked to more than 50 deaths// nationwide since 1990. About 8 million people donate blood and about 4.5 million patients receive transfusions each year. Testing for the antibodies in donated blood is difficult and not part of routine screening of the nation's blood supply.

The condition - transfusion-related acute lung injury, or TRALI - is believed to be caused in most cases by an immune-system reaction to antibodies in the donor's blood. Though it produces lung damage that is generally reversible, TRALI is a leading cause of death for transfusion recipients. It kills 5% to 10% of patients who develop it. Doctors believe it is underreported because its symptoms - including shortness of breath, fluid buildup in the lungs and low blood pressure - mimic those of other ailments.

The FDA sent a letter to transfusion specialists nationwide describing TRALI and warning that "recognition of symptoms and immediate treatment are imperative." The FDA said that it has received reports of more than 50 TRALI deaths since 1990, but that the full scope of the problem is unclear because of misdiagnosis or underreporting.

These conditions are routinely treated with diuretics, or drugs that decrease body fluid by increasing urine production. But diuretics can be dangerous and even deadly for TRALI patients, who need more fluids.
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical group Allied ... as new board chair for Orange County health care system CalOptima Friday. CalOptima ... soon-to-be former chair Mark Refowitz’s term, which runs through June 30 of this ...
(Date:3/28/2017)... San Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... million people suffering from acne, access to quality care can be limited while the ... skincare company that offers customized prescription acne care for every customer online, today released ...
(Date:3/28/2017)... ... , ... The Executives, Staff & Clients of MGE: Management Experts joined forces ... Literacy Campaign at their Semi-Annual Graduation and Fundraiser Event at MGE’s St. Petersburg Office. ... number 14 internationally in literacy. Statistically, a direct relation can be a found between ...
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Camp Conference in Atlantic City March 13-16, was a busy spot this year. ... professional staff discussed strategies for preventing outbreaks among camp communities during the upcoming ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... 28, 2017  Medeon Biodesign, Inc., a ... pleased to announce that the Company led and ... Orthopedics, Inc., a San Jose, CA ... for orthopedic extremity applications.  The ... primarily due to procedure volume growth, lifestyle influences ...
(Date:3/27/2017)... Israel , March 27, 2017 ... THXBY), a specialty clinical-stage pharmaceutical company specializing in the development ... its public offering in the United ... (ADSs), each ADS representing 40 ordinary shares of ... ADS. In addition, Therapix has granted the underwriters ...
Breaking Medicine Technology: